Metraipolis › archive › dc_06afc44c2a63

Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer — Europe PMC PMID:40998733

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40998733
DOI
10.2967/jnumed.125.269707
License (as archived)
solo-consultazione
Archived
2026-11-08T20:02:57.865Z
SHA-256 of the archived text
fe54639be3d16f90e8f5272fbbad7f48b5321c69fef19f5bccd5e230406cf155
Stable URL of this page
https://metraipolis.com/documento/dc_06afc44c2a63

How to cite

Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer — Europe PMC PMID:40998733 — Europe PMC (en), https://europepmc.org/article/MED/40998733 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_06afc44c2a63 (Metraipolis archive dc_06afc44c2a63, sha256 fe54639be3d16f90e8f5272fbbad7f48b5321c69fef19f5bccd5e230406cf155)
BibTeX
@misc{dc06afc44c2a63,
  title = {Preclinical Evaluation of [212Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate Cancer — Europe PMC PMID:40998733},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40998733},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_06afc44c2a63; sha256 fe54639be3d16f90e8f5272fbbad7f48b5321c69fef19f5bccd5e230406cf155},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40998733. Agents can read the archived copy with the MCP tool read_document.